
BUDA JUICE, INC.
79
Recent developments include the company's full year fiscal 2025 financial results announcement, a conference call and webcast for these results, completion of the IPO over-allotment option, and initiation of analyst coverage with a Buy rating by Roth Capital.
- Buda Juice reported full year fiscal 2025 financial results on March 26, 2026, providing insights into its financial performance [N2].
- The company announced a conference call and webcast for its fourth quarter and full year fiscal 2025 financial results on March 12, 2026 [N3].
- Buda Juice announced the full exercise of underwriters’ over-allotment option in connection with its initial public offering on January 22, 2026 [N4].
- Roth Capital initiated coverage of Buda Juice with a Buy rating on September 28, 2026, indicating analyst interest [N1].
Buda Juice, Inc. pioneers the UltraFresh™ juice category by delivering cold-crafted citrus-based juices, lemonades, and wellness shots that are never heat-treated or HPP-processed. The company maintains a continuous 35°F cold chain from orchard to retail shelf, enabling an 8-12 day shelf life that balances freshness with retail distribution needs. Founded in 2013 and initially operating retail stores, Buda Juice shifted in 2020 to distribution through large retailers, focusing on perfecting juice quality and freshness. Its product portfolio includes organic wellness shots, fresh citrus juices, lemonades, limeades, and private label offerings, serving multiple market segments. The company operates an asset-light model with integrated production and outsourced logistics, supported by long-term grower relationships and an experienced retail network. Buda Juice is expanding geographically via a three-hub model to serve large U.S. population segments. Manufacturing facilities hold SQF Level II certification and comply with FDA food safety regulations. The company completed its IPO in January 2026 and trades on NYSE American under ticker BUDA [S1][S2].
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Buda Juice, Inc. operates in the UltraFresh™ juice category, producing cold-crafted citrus-based beverages with a continuous cold chain process to preserve freshness and nutrients. The company has a diversified product portfolio including organic wellness shots and private label products. As of September 30, 2026, it reported net income of $866,000 and strong liquidity with a current ratio of 15.52. The company completed its IPO in January 2026 and is expanding geographically beyond Texas. Risks include limited operating history outside Texas, competitive pressures, and the need to maintain product quality and brand reputation [S1][S2][N1][N2][N3][N4].
Buda Juice addresses a growing consumer demand for genuinely fresh, clean-label beverages by pioneering the UltraFresh™ juice category with a unique cold chain process that preserves taste and nutrients. Its diversified product portfolio, including organic wellness shots and private label products, allows access to multiple market segments. The company's asset-light model and established grower and retail relationships provide operational flexibility and scalability. Geographic expansion through a multi-hub strategy aims to increase market reach beyond Texas. Strong liquidity and recent profitability provide a foundation for disciplined growth. Analyst coverage initiation with a Buy rating reflects positive market interest [N1][S1][S2].
Buda Juice operates in a highly competitive beverage industry with larger, better-capitalized competitors that may leverage scale, marketing budgets, and vertical integration to challenge market share. The company's limited operating history outside Texas and evolving UltraFresh™ category create uncertainty around demand and growth scalability. Maintaining continuous cold chain logistics over wider geographies presents operational challenges. Brand reputation depends on consistent product quality and safety; any lapses could harm consumer perception. Competitive pressures may lead to price reductions and increased promotional costs, impacting margins. The company also faces risks related to supply chain disruptions and the need for additional capital to support expansion [S1][S2].
Buda Juice's competitive advantages stem from its proprietary end-to-end cold chain infrastructure maintaining continuous 35°F temperature control, which requires significant capital and expertise to replicate. Its asset-light model balances quality control with operational flexibility by integrating production while outsourcing logistics. Long-term relationships with citrus growers secure consistent premium fruit supply at competitive prices, creating a barrier to entry. The executive team's extensive experience and established relationships with major U.S. grocery retailers support a strong retail network. The turnkey retail model eliminates the need for retailers to invest in specialized equipment or labor, positioning Buda Juice as a category resource rather than a simple vendor. These factors collectively create significant barriers for competitors to replicate the UltraFresh™ juice category and scale effectively [S1].
• Limited Operating History and Geographic Concentration: Buda Juice's operating history is primarily limited to Texas and surrounding states, making it difficult to evaluate future prospects and growth outside its current region. Expansion involves logistical challenges in cold chain distribution and requires attracting and retaining qualified personnel.
• Competitive Industry Landscape: The beverage industry is highly competitive with larger companies having greater resources, established brands, and distribution capabilities. Competitors may replicate freshness claims or invest heavily in marketing, potentially reducing Buda Juice's shelf space and sales velocity.
• Brand and Product Quality Dependence: The company's success depends on maintaining consumer perception of product freshness, safety, and quality. Any inconsistency or food safety issues could materially harm the brand and business.
• Operational and Supply Chain Risks: Scaling the cold chain infrastructure and securing cost-effective production and supply of premium fruit pose operational risks. Supply chain disruptions could affect product availability and costs.
• Financial and Capital Access Risks: Sustaining profitability depends on multiple factors including product performance and market conditions. Access to capital on reasonable terms is necessary to support growth and expansion plans.
Business trends: Expansion of UltraFresh™ juice category with geographic growth beyond Texas and diversification of product portfolio.
Execution milestones: Completion of IPO and over-allotment exercise, establishment of multi-hub production facilities, and initiation of analyst coverage.
Key risks: Operational challenges in cold chain logistics, competitive pressures from larger beverage companies, and maintaining consistent product quality and brand reputation.
High visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Buda Juice, Inc. operates in the UltraFresh™ juice category, producing cold-crafted citrus-based juices, lemonades, and wellness shots that are never heat-treated or HPP-processed, maintaining continuous 35°F cold chain from fruit to retail shelf to preserve freshness and nutrients [S1].
- The company was founded in 2013, started retail operations in 2014, and shifted to distribution through large retailers in 2020, currently serving Texas and surrounding states with plans for geographic expansion [S1].
- Buda Juice's product portfolio includes organic wellness shots, fresh citrus juices, lemonades, limeades, and private label products, produced using their cold chain process [S1].
- The company emphasizes an asset-light model with integrated production and outsourced logistics, leveraging long-term grower relationships and a retail network with experienced leadership [S1].
- Buda Juice maintains SQF Level II certification for its manufacturing facilities and complies with FDA food safety regulations [S1].
- As of September 30, 2026, Buda Juice had $19.3 million in cash and equivalents, $22.6 million in current assets, and $1.46 million in current liabilities, resulting in a current ratio of 15.52 and a cash ratio of 13.24, indicating strong liquidity [S2].
- The company reported net income of $866,000 and basic and diluted EPS of $0.07 for the quarter ended September 30, 2026 [S2].
- Buda Juice completed its IPO in January 2026 and began trading on NYSE American under ticker BUDA [S1].
- The company faces risks including limited operating history outside Texas, competition from larger beverage companies, challenges in scaling cold chain logistics, and the need to maintain brand reputation for freshness and quality [S1].
- Recent news includes full year fiscal 2025 financial results, a conference call announcement, full exercise of underwriters’ over-allotment option in IPO, and initiation of analyst coverage with a Buy rating by Roth Capital [N2][N3][N4][N1].
Generated 2026-11-15
- S1 | 2026-03-26 | 10-K
- S2 | 2026-11-12 | 10-Q
- N1 | 2026-09-28 | www.nasdaq.com | Roth Capital Initiates Coverage of Buda Juice with Buy | https://www.nasdaq.com/articles/roth-capital-initiates-coverage-buda-juice-buy
- N2 | 2026-03-26 | www.nasdaq.com | Buda Juice Reports Full Year Fiscal 2025 Financial Results | https://www.nasdaq.com/press-release/buda-juice-reports-full-year-fiscal-2025-financial-results-2026-03-26
- N3 | 2026-03-12 | www.nasdaq.com | Buda Juice Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call and Webcast | https://www.nasdaq.com/press-release/buda-juice-announces-fourth-quarter-and-full-year-fiscal-2025-financial-results
- N4 | 2026-01-22 | www.nasdaq.com | Buda Juice Announces Full Exercise of Underwriters’ Over-Allotment Option in Connection with Initial Public Offering | https://www.nasdaq.com/press-release/buda-juice-announces-full-exercise-underwriters-over-allotment-option-connection
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


